Meeting
2019 ASCO Annual Meeting
Intratumoral CD3+ and CD8+ T-cell densities in patients with deficient DNA mismatch repair (dMMR) metastatic colorectal cancer (mCRC) receiving programmed death-1 (PD-1) blockade.
Authors
Sakti Chakrabarti
Mayo Clinic, Rochester, MN
Sakti Chakrabarti , Lucas J. Huebner , Heidi Diann Finnes , Andrea Muranyi , Shalini Singh , June Clements , Robert R. McWilliams , Joleen Marie Hubbard , Kandavel Shanmugam , Frank A. Sinicrope
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal (Colorectal) Cancer
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Colorectal Cancer–Advanced Disease
Citation
J Clin Oncol 37, 2019 (suppl; abstr 3532)
DOI
10.1200/JCO.2019.37.15_suppl.3532
Abstract #
3532
Poster Bd #
24
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Annual Meeting
Spatially resolved multi-region proteomics for prediction of clinical outcome in deficient mismatch repair metastatic colorectal cancer treated with PD-1 blockade.
First Author: Bahar Saberzadeh Ardestani
Poster
2024 ASCO Genitourinary Cancers Symposium
Preclinical testing of a novel PD-L1 inhibitor for the treatment of renal cell carcinoma.
First Author: Michelle Hsu
Poster
2022 ASCO Annual Meeting
Dysfunctional CD8+ T cells in the tumor microenvironment are associated with response to nivolumab in mismatch repair deficient (dMMR) or hypermutated ovarian (OVCA) or endometrial cancer (EC).
First Author: Claire Frances Friedman
Poster
2022 ASCO Annual Meeting
A phase 1 first-in-human dose finding/randomized phase 2 study of IMM60 and pembrolizumab (PEM) in advanced melanoma and non–small cell lung cancer (NSCLC; IMP-MEL).
First Author: Nicholas Coupe